Steroid study for COVID brain fog halted early
NCT ID NCT05986422
First seen May 13, 2026 · Last updated May 20, 2026 · Updated 3 times
Summary
This study tested whether a 6-week course of the steroid methylprednisolone could improve memory and thinking in adults with post-COVID syndrome (brain fog). 96 participants were randomly assigned to receive either the drug or a placebo. The trial was terminated early, so results are limited. The goal was to see if this anti-inflammatory approach could ease cognitive symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-COVID-19 SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.